Uncommon phenotypes of BCR::ABL1-positive chronic myelogenous leukemia.
Therapeutic options against BCR-ABL1 T315I-positive chronic myelogenous leukemia.
"Preleukemic or smoldering" chronic myelogenous leukemia (CML):BCR-ABL1 positive: A brief case report.
Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring.
Jabbour E, Kantarjian H.
Am J Hematol. 2024 Nov;99(11):2191-2212. doi: 10.1002/ajh.27443. Epub 2024 Aug 2.
Uncommon phenotypes of BCR::ABL1-positive chronic myelogenous leukemia.
Jajosky AN, Lichtman MA.
Haematologica. 2025 Sep 1;110(9):1912-1920. doi: 10.3324/haematol.2025.287792. Epub 2025 May 15.
Response and Resistance to BCR-ABL1-Targeted Therapies.
Braun TP, Eide CA, Druker BJ.
Cancer Cell. 2020 Apr 13;37(4):530-542. doi: 10.1016/j.ccell.2020.03.006.
Chronic Myeloid Leukemia: A Review.
Jabbour E, Kantarjian H.
JAMA. 2025 May 13;333(18):1618-1629. doi: 10.1001/jama.2025.0220.
The specificity of asciminib, a potential treatment for chronic myeloid leukemia, as a myristate-pocket binding ABL inhibitor and analysis of its interactions with mutant forms of BCR-ABL1 kinase.
Manley PW, Barys L, Cowan-Jacob SW.
Leuk Res. 2020 Nov;98:106458. doi: 10.1016/j.leukres.2020.106458. Epub 2020 Sep 29.
Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring.
Jabbour E, Kantarjian H.
Am J Hematol. 2022 Sep;97(9):1236-1256. doi: 10.1002/ajh.26642. Epub 2022 Jul 6.
Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions.
Osman AEG, Deininger MW.
Blood Rev. 2021 Sep;49:100825. doi: 10.1016/j.blre.2021.100825. Epub 2021 Mar 16.
Chronic Myeloid Leukemia in Children and Adolescents.
Gotesman M, Raheel S, Panosyan EH.
Adv Pediatr. 2023 Aug;70(1):145-155. doi: 10.1016/j.yapd.2023.04.002. Epub 2023 May 12.
Chronic myeloid leukaemia: Biology and therapy.
Wang Y, Liang ZJ, Gale RP, Liao HZ, Ma J, Gong TJ, Shao YQ, Liang Y.
Blood Rev. 2024 May;65:101196. doi: 10.1016/j.blre.2024.101196. Epub 2024 Mar 27.
Chronic myelogenous leukemia, BCR-ABL1+.
Vardiman JW.
Am J Clin Pathol. 2009 Aug;132(2):250-60. doi: 10.1309/AJCPUN89CXERVOVH.
